Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

DIAGENS

Biotech & Life Sciences · Hangzhou, China · Founded 2016 · IPO 2026 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.91B
Market cap · Apr/2026
Revenue
$23M
Latest reported FY

Investors

18 investors on DIAGENS's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage
Zijingang Venture Capital
Yuhang Fund
Series A 3 investors entered at this stage
Donghai Polymerization
Yueqing Deheng Investment
Huadan Angel
Series B+ 13 investors entered at this stage
Yingberli Investment
Meihong Investment
Jiayuan Venture Capital
InterChina Partners
Zhejiang Shoucheng
Peking University
China Venture Capital HRVC
Tenghua Assets
Grand Flight Investment
Shenzhen Guozhong Venture Capital Management
Xiangjiang Liyuan Investment
Tsinghua University
Meinian Onehealth

Global footprint

Where DIAGENS has talent and traffic

Web traffic by country
180 monthly visits
across markets
🇭🇰 Hong Kong111.1%
Top 1 markets shown

See DIAGENS on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo